Matthew W. Strobeck

Chief Investment Officer & Managing Partner at Birchview Capital LP

Matthew W. Strobeck

Matthew W. Strobeck

Chief Investment Officer & Managing Partner at Birchview Capital LP

Overview
Career Highlights

Birchview Capital LP

RelSci Relationships

278

Number of Boards

11

Birthday

1973

Age

45

Relationships
RelSci Relationships are individuals Matthew W. Strobeck likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Monteris Medical US, Inc.

Relationship likelihood: Strong

Co-Director of the Malaysia-MIT Biotechnology Partnership Program at Massachusetts Institute of Technology

Relationship likelihood: Strong

Co-Founder at Crabtree Partners LLC

Relationship likelihood: Strong

Advisory Director at Sit Investment Associates, Inc.

Relationship likelihood: Strong

General Partner at The Vertical Group LP

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Accelerate Diagnostics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Biodesix, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Tepha, Inc.

Relationship likelihood: Strong

Chief Technology Officer at Biodesix, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Global Kinetics Corp. Ltd.

Relationship likelihood: Strong

Paths to Matthew W. Strobeck
Potential Connections via
Relationship Science
You
Matthew W. Strobeck
Chief Investment Officer & Managing Partner at Birchview Capital LP
Career History
Chief Investment Officer & Managing Partner
2014 - Current

Birchview Capital LP is an American private company located in Burlington, VT, with domestic subsidiaries. The firm provides investment advice. It was founded in 2014 by Matthew William Strobeck, who has been the CEO since that date.

Independent Director, Member, Audit Committee
Current

Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Partner
2003 - 2011

Westfield Capital Management (WCM) is a growth manager that seeks to invest in the reasonably priced stocks of companies with high earnings potential. The firm uses fundamental, bottom-up research to identify growth companies across all market-caps. They seek to identify companies capable of providing consistently high or accelerating earnings growth. WMC supervises mainly investments in publicly traded, domestic growth equities, with investment products focusing on each segment of the capitalization spectrum. The firm also supervises investments in foreign equities that are traded on US stock exchanges and in US dollars, American Depositary Receipts (ADRs), American Depositary Shares (ADS), and Global Depositary Receipts (GDRs).WMC's investment strategies include: Large Cap Growth, Small/Mid Cap Growth, Mid Cap Growth, All Cap Growth, Dividend Growth, Sustainable Growth, Micro Cap, and Select Growth Equity. The following strategies are closed to new investors: Small Cap Growth, Fixed Income, and Life Sciences.With the exception of their Mid Cap Strategy, WMC does not generally invest in derivatives, options, or privately held securities, and does not permit short selling. The Micro-Cap Strategy permits the usage of leveraging techniques, short selling, frequent trading, investments in private securities, and investments in derivatives or options. As such, the Micro-Cap Strategy will enter into a short position in a broad market index ETF. Under normal market conditions, the firm's long-only equity products don't use a frequent trading strategy; however, in certain market conditions, trading activity within products may increase.

Boards & Committees
Member, Board of Directors
2018 - Current
Member, Board of Directors
2014 - Current
Member, Board of Directors
2012 - Current
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2009
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew W. Strobeck. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew W. Strobeck's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew W. Strobeck.